Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...

Like its peers, the impact of the present geopolitical situation may have curbed fiscal second-quarter profits for Medtronic.

Luxembourg's Ministry of Health and Social Security has reported that a safety notice regarding certain models... }} ...

Defensive industries, like healthcare, are more attractive to income investors. That's because companies in this sector are ...

Medtronic has issued a second alert letter to patients regarding shortened battery life of the MiniMed 600 and 700 series insulin pumps. The affected products include the MiniMed 630G, 670G ...

This recall does not involve removing all products. If users experience significantly reduced battery life, they should contact Medtronic to determine if a new pump is needed regardless of whether ...

Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to ...

It boasts dozens of products across several ... biggest growth driver lately. Medtronic's innovations in the field include its MiniMed 780G, the only insulin pump with meal-detection technology ...

The FDA recently announced critical recalls on several widely used medical devices, including Life2000 ventilators, Medtronic's MiniMed insulin pumps and Boston Scientific's Obsidio conformable ...

The clinical studies required by regulators prior to marketing are small and over-reliant on bench testing in relation to "predicate" products. Once a pump is available on the market, insufficient ...